Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Leukosilk tape 1.25cm
20100000435
|
Leukosilk tape 1.25cm | Surgical Adhesive Tape | Dressings | No data available |
|
Leukosilk tape 2.5cm
20100000436
|
Leukosilk tape 2.5cm | Surgical Adhesive Tape | Dressings | No data available |
|
Leukosilk tape 5cm
20100000437
|
Leukosilk tape 5cm | Surgical Adhesive Tape | Dressings | No data available |
|
Leuprorelin 11.25mg inj vials
0803042N0AAABAB
|
Leuprorelin acetate | Leuprorelin acetate | Malignant Disease and Immunosuppression | No data available |
|
Leuprorelin 22.5mg inj vials
0803042N0AAAEAE
|
Leuprorelin acetate | Leuprorelin acetate | Malignant Disease and Immunosuppression | No data available |
|
Leuprorelin 3.75mg inj vials
0803042N0AAAAAA
|
Leuprorelin acetate | Leuprorelin acetate | Malignant Disease and Immunosuppression | No data available |
|
Leustat 10mg/10ml solution for infusion vials
0801030C0BBAAAA
|
Leustat | Cladribine | Malignant Disease and Immunosuppression | No data available |
|
Levamisole 25mg tablets
0505020L0AAAFAF
|
Levamisole hydrochloride | Levamisole hydrochloride | Infections | No data available |
|
Leveraxo 10mg modified-release tablets
0407020ADBPABAF
|
Leveraxo | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Leveraxo 20mg modified-release tablets
0407020ADBPACAG
|
Leveraxo | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Leveraxo 30mg modified-release tablets
0407020ADBPADAR
|
Leveraxo | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Leveraxo 40mg modified-release tablets
0407020ADBPAEAH
|
Leveraxo | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Leveraxo 5mg modified-release tablets
0407020ADBPAAAK
|
Leveraxo | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Leveraxo 60mg modified-release tablets
0407020ADBPAFAQ
|
Leveraxo | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Leveraxo 80mg modified-release tablets
0407020ADBPAGAI
|
Leveraxo | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Levetiracetam 1.5g/100ml infusion bags
0408010A0AAARAR
|
Levetiracetam | Levetiracetam | Central Nervous System | No data available |
|
Levetiracetam 300mg/5ml oral liquid
0408010A0AAADAD
|
Levetiracetam | Levetiracetam | Central Nervous System | No data available |
|
Levetiracetam 400mg/5ml oral liquid
0408010A0AAAEAE
|
Levetiracetam | Levetiracetam | Central Nervous System | No data available |
|
Levetiracetam 500mg/100ml infusion bags
0408010A0AAAPAP
|
Levetiracetam | Levetiracetam | Central Nervous System | No data available |
|
Levobupivacaine 25mg/10ml solution for injection ampoules
1502010V0AAAAAA
|
Levobupivac hydrochloride | Levobupivacaine hydrochloride | Anaesthesia | No data available |
|
Levobupivacaine 75mg/10ml solution for injection ampoules
1502010V0AAACAC
|
Levobupivac hydrochloride | Levobupivacaine hydrochloride | Anaesthesia | No data available |
|
Levocabastine 0.05% nasal spray
1202010K0AAAAAA
|
Levocabastine (Nasal) | Levocabastine | Ear, Nose and Oropharynx | No data available |
|
Levocabastine 0.5mg/ml eye drops
1104020P0AAAAAA
|
Levocabastine (Eye) | Levocabastine | Eye | No data available |
|
Levocarnitine 1g/5ml solution for injection ampoules
0908010C0AAAHAH
|
Levocarnitine | Levocarnitine | Nutrition and Blood | No data available |
|
Levocarnitine 330mg tablets
0908010C0AAAIAI
|
Levocarnitine | Levocarnitine | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.